Australia announced free access to Carvykti, a CAR T-cell therapy for multiple myeloma, in public hospitals. The breakthrough treatment typically costs over $200,000 per patient but will now be publicly funded.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
The emerging cancer treatment that’s exciting scientists: ‘We’ve just scratched the surface on what’s possible’ | Cancer | The Guardian
Over $200,000 per patient Treatment cost without funding
Public Hospitals Australia-Wide nationwide Access scope
Free In Public Hospitals access expansion
$200,000+ Per Patient treatment cost typically